Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03246971 · ClinicalTrials.gov registry record · Phase 2
Study of Wafermine™ for Post-bunionectomy or Abdominoplasty Pain
A Phase 2 study of Acute Pain and Bunion, sponsored by iX Biopharma.
- Completed
- Registry status
- Phase 2
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT03246971 is a Phase 2 study of Acute Pain and Bunion that has completed, run by iX Biopharma. The registered enrollment target is 125 participants, below the 266-participant average among 50 other Acute Pain trials with a reported enrollment target (53% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03246971, a Phase 2 study of Acute Pain and Bunion, has completed, sponsored by iX Biopharma.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the safety and effectiveness of Wafermine™ for post-bunionectomy or post-abdominoplasty pain over a 24 hours period. For subjects undergoing bunionectomy, 2 out of 3 subjects will receive Wafermine™ and 1 out of 3 subjects will receive placebo. For subjects undergoing abdominoplasty, 3 out of 4 subjects will receive Wafermine™ and 1 out of 4 subjects will receive placebo.
Conditions Studied
Interventions
- DRUG Placebos
- DRUG Wafermine™ 50 mg
- DRUG Wafermine™ 75 mg
- DRUG Wafermine™ 25 mg
Study Locations (1)
California
- Lotus Clinical Research - Pasadena
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2017-08-24 |
| Est. Completion | 2018-07-17 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03246971
The ClinicalTrials.gov registry entry for NCT03246971 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 266-participant average among 50 other Acute Pain trials with a reported enrollment target (53% lower). The listed sponsor is iX Biopharma, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Acute Pain appearing as the primary indexed condition, and to 4 interventions - of which Placebos is the first listed.
NCT03246971 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03246971 about?
NCT03246971 is a clinical study titled "Study of Wafermine™ for Post-bunionectomy or Abdominoplasty Pain". This study evaluates the safety and effectiveness of Wafermine™ for post-bunionectomy or post-abdominoplasty pain over a 24 hours period. For subjects undergoing bunionectomy, 2 out of 3 subjects will receive Wafermine™ and 1 out of 3 subjects will receive placebo. For subjects undergoing abdominopl...
What is the current status of trial NCT03246971?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 125 participants. The study started on 2017-08-24. Estimated completion is 2018-07-17.
What conditions does trial NCT03246971 study?
This clinical trial studies the following conditions: Acute Pain, Bunion, Abdominoplasty.
What interventions are being tested in trial NCT03246971?
The interventions under investigation include: Placebos (DRUG), Wafermine™ 50 mg (DRUG), Wafermine™ 75 mg (DRUG), Wafermine™ 25 mg (DRUG).
Who is sponsoring clinical trial NCT03246971?
This trial is sponsored by iX Biopharma, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03246971 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reducing Pain From Wisdom Molar Extractions
RECRUITING · Phase 2
-
Twin Block, Pain Medications and Third Molar Extractions
RECRUITING · Phase 2
-
Liposome Bupivacaine Interscalene Total Shoulder
COMPLETED · Phase 2
-
Acetaminophen Versus IV Hydromorphone for Pain in the Elderly in the ED
COMPLETED · Phase 2
-
Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)
COMPLETED · Phase 2
-
A Phase 2 Study to Evaluate Analgesic Effect of IV CR845 For Pain Following Bunionectomy Surgery
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.